Statement of Cash FlowsIndirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $291,640 $273,170 Accounts receivable (net) 105,650 98,110 Inventories 298,250 290,480 Investments 0 112,540 Land 152,980 0 Equipment 329,060 256,820 Accumulated depreciationequipment (77,040) (69,250) Total assets $1,100,540 $961,870 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $199,200 $189,490 Accrued expenses payable (operating expenses) 19,810 25,010 Dividends payable 11,010 8,660 Common stock, $10 par 59,430 47,130 Paid-in capital: Excess of issue price over par-common stock 223,410 130,810 Retained earnings 587,680 560,770 Total liabilities and stockholders equity $1,100,540 $961,870 Additional data obtained from an examination of the accounts in the ledger for 20Y3 are as follows: The investments were sold for $131,670 cash. Equipment and land were acquired for cash. There were no disposals of equipment during the year. The common stock was issued for cash. There was a $72,120 credit to Retained Earnings for net income. There was a $45,210 debit to Retained Earnings for cash dividends declared. Required: Prepare a statement of cash flows, using the indirect method of presenting cash flows from operating activities. Use the minus sign to indicate cash out flows, cash payments, decreases in cash, or any negative adjustments. Livers Inc. Statement of Cash Flows For the Year Ended December 31, 20Y3 Cash flows from operating activities: $ Adjustments to reconcile net income to net cash flow from operating activities: Changes in current operating assets and liabilities: Net cash flow from operating activities $ Cash flows from investing activities: $ Net cash flow used for investing activities Cash flows from financing activities: $ Net cash flow from financing activities $ Cash at the beginning of the year Cash at the end of the year $